238 related articles for article (PubMed ID: 22405131)
21. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.
Ray A; Prefontaine KE; Ray P
J Biol Chem; 1994 Apr; 269(17):12940-6. PubMed ID: 8175711
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
Niravath P; Chen B; Chapman JW; Agarwal SK; Welschhans RL; Bongartz T; Kalari KR; Shepherd LE; Bartlett J; Pritchard K; Gelmon K; Hilsenbeck SG; Rimawi MF; Osborne CK; Goss PE; Ingle JN
Clin Breast Cancer; 2018 Feb; 18(1):78-87. PubMed ID: 29128193
[TBL] [Abstract][Full Text] [Related]
23. IL-17A induces pro-inflammatory cytokines production in macrophages via MAPKinases, NF-κB and AP-1.
Chen J; Liao MY; Gao XL; Zhong Q; Tang TT; Yu X; Liao YH; Cheng X
Cell Physiol Biochem; 2013; 32(5):1265-74. PubMed ID: 24247374
[TBL] [Abstract][Full Text] [Related]
24. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
Ray P; Ghosh SK; Zhang DH; Ray A
FEBS Lett; 1997 Jun; 409(1):79-85. PubMed ID: 9199508
[TBL] [Abstract][Full Text] [Related]
25. Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.
Qin S; Ingle JN; Liu M; Yu J; Wickerham DL; Kubo M; Weinshilboum RM; Wang L
Breast Cancer Res; 2017 Aug; 19(1):95. PubMed ID: 28821270
[TBL] [Abstract][Full Text] [Related]
26. AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies.
Wong C; Wang X; Smith D; Reddy K; Chen S
Breast Cancer Res Treat; 2012 Jul; 134(2):671-81. PubMed ID: 22706627
[TBL] [Abstract][Full Text] [Related]
27. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
[TBL] [Abstract][Full Text] [Related]
28. The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway.
Demyanets S; Pfaffenberger S; Kaun C; Rega G; Speidl WS; Kastl SP; Weiss TW; Hohensinner PJ; Dietrich W; Tschugguel W; Bochkov VN; Awad EM; Maurer G; Huber K; Wojta J
Thromb Haemost; 2006 Jan; 95(1):107-16. PubMed ID: 16543969
[TBL] [Abstract][Full Text] [Related]
29. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
31. Identification of common transcriptional regulatory elements in interleukin-17 target genes.
Shen F; Hu Z; Goswami J; Gaffen SL
J Biol Chem; 2006 Aug; 281(34):24138-48. PubMed ID: 16798734
[TBL] [Abstract][Full Text] [Related]
32. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.
Zhu L; Wu Y; Wei H; Xing X; Zhan N; Xiong H; Peng B
Mol Immunol; 2011 Jan; 48(4):647-56. PubMed ID: 21145111
[TBL] [Abstract][Full Text] [Related]
33. 17beta-estradiol inhibits the production of RANTES in human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):420-7. PubMed ID: 12603855
[TBL] [Abstract][Full Text] [Related]
34. The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
Ropars V; Despouy G; Stern MH; Benichou S; Roumestand C; Arold ST
PLoS One; 2009 Aug; 4(8):e6567. PubMed ID: 19668332
[TBL] [Abstract][Full Text] [Related]
35. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
[TBL] [Abstract][Full Text] [Related]
36. Selected contribution: estrogen receptor-alpha gene transfer inhibits proliferation and NF-kappaB activation in VSM cells from female rats.
Sharma RV; Gurjar MV; Bhalla RC
J Appl Physiol (1985); 2001 Nov; 91(5):2400-6; discussion 2389-90. PubMed ID: 11641387
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal regulation of 17beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer.
Yang J; Wang Y; Gao Y; Shao J; Zhang XJ; Yao Z
Cytokine; 2009 Jun; 46(3):382-91. PubMed ID: 19401270
[TBL] [Abstract][Full Text] [Related]
39. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage.
Suzuki T; Yu HP; Hsieh YC; Choudhry MA; Bland KI; Chaudry IH
J Cell Physiol; 2008 Mar; 214(3):662-72. PubMed ID: 17786973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
